
Thalassemia Bal Sewa Yojana (2017) : Assessing Public Support for Children with Genetic Blood Disorders.
Thalassemia is a major public health concern in India, which accounts for approximately 25% of the global β thalassemia burden (Sharma et al., 2023). Controlling this burden requires awareness programmes, prenatal screening, genetic counselling and accessible diagnostic facilities, particularly in rural areas (Sharma et al., 2023). In India, the Thalassemia Bal Sewa Yojana was launched in 2017 by the Union Ministry of Health and Family Welfare in association with Coal India Limited. Supported through corporate social responsibility (CSR) funds, the scheme provides financial assistance of up to ₹10 lakh to eligible patients for bone marrow transplantation (Ministry of Health and Family Welfare, 2020). The scheme demonstrates how public institutions and corporate support can help make specialised treatment more accessible to children from economically disadvantaged families.






